Episealer® Talus registered for sale in Italy and Spain
Episurf Medical (NASDAQ: EPIS B) today announces that the company’s ankle implant Episealer® Talus, recently CE approved, is now additionally approved for sale in Italy and Spain. Notifications to applicable authorities have been completed through National Health Information System (NSIS) Database in Italy and CCPS (Comunicaciones de Productos Sanitaros) in Spain, which fulfils the regulatory requirements for distribution in the corresponding countries. Episealer® Talus is further undergoing registration in the Medical Device Registration portal Infarmed in Portugal and that registration is